Literature DB >> 1907993

Abnormal regulation of IFN-gamma secretion in vitamin A deficiency.

J A Carman1, C E Hayes.   

Abstract

T lymphocytes from vitamin A-deficient (A-) mice show a decreased ability to stimulate B lymphocytes for Ag-specific secondary IgG1 responses in vivo and in vitro. Experiments reported here traced the molecular basis for this functional defect to an overproduction of IFN-gamma by A- CD4+ T cells compared with cells from A-sufficient (A+) mice. Secretion of IL-2 and IL-4 by cells from A- and A+ mice was equivalent. Retinoic acid supplementation in vitro decreased IFN-gamma secretion from A- T cells, indicating that IFN-gamma production is retinoid-responsive. Adding IFN-gamma neutralizing antibodies to cultures established with cells from immune A- mice substantially increased IgG1 production, whereas IL-4 addition moderately increased IgG1 production. Adding retinoic acid to the cultures either at initiation, or 48 h later, fully restored IgG1 production by A- cultures to the level of A+ control cultures. These results are consistent with a role for vitamin A in negatively regulating IFN-gamma secretion.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907993

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Quantitation of parvalbumin+ neurons and human immunodeficiency virus type 1 (HIV-1) regulatory gene expression in the HIV-1 transgenic rat: effects of vitamin A deficiency and morphine.

Authors:  Shireen Sultana; Huifen Li; Adam Puche; Odell Jones; Joseph L Bryant; Walter Royal
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

2.  Effects of vitamin A deficiency and opioids on parvalbumin + interneurons in the hippocampus of the HIV-1 transgenic rat.

Authors:  Ming Guo; Joseph Bryant; Shireen Sultana; Odell Jones; Walter Royal
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity.

Authors:  S P Spencer; C Wilhelm; Q Yang; J A Hall; N Bouladoux; A Boyd; T B Nutman; J F Urban; J Wang; T R Ramalingam; A Bhandoola; T A Wynn; Y Belkaid
Journal:  Science       Date:  2014-01-24       Impact factor: 47.728

4.  Vitamin A supplementation increases ratios of proinflammatory to anti-inflammatory cytokine responses in pregnancy and lactation.

Authors:  S E Cox; P Arthur; B R Kirkwood; K Yeboah-Antwi; E M Riley
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

5.  Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathway.

Authors:  Heng-Kwei Chang; Wu-Shiun Hou
Journal:  J Interferon Cytokine Res       Date:  2014-10-24       Impact factor: 2.607

Review 6.  Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids.

Authors:  Sapna Patel; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2015-07-17       Impact factor: 4.388

7.  Retinoic Acid Modulates Hyperactive T Cell Responses and Protects Vitamin A-Deficient Mice against Persistent Lymphocytic Choriomeningitis Virus Infection.

Authors:  Yuejin Liang; Panpan Yi; Xiaofang Wang; Biao Zhang; Zuliang Jie; Lynn Soong; Jiaren Sun
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

Review 8.  Retinoic acid in the immune system.

Authors:  Karina Pino-Lagos; Micah J Benson; Randolph J Noelle
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

9.  Aberrant T-cell function in vitro and impaired T-cell dependent antibody response in vivo in vitamin A-deficient rats.

Authors:  U Wiedermann; L A Hanson; H Kahu; U I Dahlgren
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

10.  A vitamin A deficient diet enhances proinflammatory cytokine, Mu opioid receptor, and HIV-1 expression in the HIV-1 transgenic rat.

Authors:  Walter Royal; Huiyun Wang; Odell Jones; Hieu Tran; Joseph L Bryant
Journal:  J Neuroimmunol       Date:  2007-02-07       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.